Interacciones medicamentosas de los anticonvulsivantes de primera línea con antipsicóticos y/o antidepresivos

dc.creatorHernández, L.
dc.creatorMarín, K.
dc.date.accessioned2017-06-01 00:00:00
dc.date.accessioned2022-02-21T20:33:12Z
dc.date.accessioned2022-09-27T12:39:03Z
dc.date.available2017-06-01 00:00:00
dc.date.available2022-02-21T20:33:12Z
dc.date.available2022-09-27T12:39:03Z
dc.date.created2017-06-01 00:00:00
dc.date.created2022-02-21T20:33:12Z
dc.date.issued2017-06-01
dc.identifier0121-7372
dc.identifierhttps://repositorio.fucsalud.edu.co/handle/001/2009
dc.identifier2462-991X
dc.identifierhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/29
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3596250
dc.languagespa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.relationFisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: A practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82.
dc.relationLeppik IE, Birnbaum AK. Epilepsy in the elderly. Ann N Y Acad Sci. 2010;1184:208–24.
dc.relationPollard JR, Delanty N. Antiepileptic drug interactions. Continuum (Minneap Minn). 2007;13(4, Epilepsy):91–105.
dc.relationGidal BE, Anderson GD, Rutecki PR, Shaw R, Lanning A. Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Epilepsy Res. 2000;42:23–31.
dc.relationPerucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61:246–55.
dc.relationKirmani BF, Robinson DM, Kikam A, Fonkem E, Cruz D. Selection of antiepileptic drugs in older people. Curr Treat Options Neurol. 2014;16:295.
dc.relationSchachter SC. Seizure disorders. Med Clin North Am. 2009;93:343–51, viii.
dc.relationBjörnsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand. 2008;118:281–90.
dc.relationMallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. The Lancet. 2007;370:185–91.
dc.relationMorán Chorro I, Marruecos L, Nogué Xarau S. Toxicología clínica. Madrid: Grupo Difusión; 2011. p. 244.
dc.relationHermann B, Seidenberg M, Jones J. The neurobehavioural comorbidities of epilepsy: Can a natural history be developed? Lancet Neurol. 2008;7:151–60.
dc.relationEttinger AB, Reed ML, Goldberg JF, Hirschfeld RM. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology. 2005;65:535–40.
dc.relationSpina E, Pisani F, de Leon J. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. Pharmacol Res. 2016;106:72–86.
dc.relationGaitatzis A, Sander JW. The long-term safety of antiepileptic drugs. CNS Drugs. 2013;27:435–55.
dc.relationDe Leon J, Santoro V, d’Arrigo C, Spina E. Interactions between antiepileptics and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2012;8:311–34.
dc.relationMauri MC, Volonteri LS, Colasanti A, Fiorentini A, de Gaspari IF, Bareggi SR. Clinical pharmacokinetics of atypical antipsychotics: A critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet. 2007;46:359–88.
dc.relationDe Leon J. The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for clinicians. Rev Psiquiatr Salud Ment. 2015;8:97–115.
dc.relationTatum WO. Antiepileptic drugs: Adverse effects and drug interactions. Continuum (Minneap Minn). 2010;16(3 Epilepsy):136–58.
dc.relationAldaz A, Ferriols R, Aumente D, Calvo MV, Farre MR, García B, et al. Monitorización farmacocinética de antiepilépticos. Farm Hosp. 2011;35:326–39.
dc.relationItaliano D, Spina E, de Leon J. Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants. Expert Opin Drug Metab Toxicol. 2014;10:1457–89.
dc.relationhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/29/18
dc.relationNúm. 2 , Año 2017 : Abril – Junio
dc.relation84
dc.relation2
dc.relation78
dc.relation26
dc.relationRevista Repertorio de Medicina y Cirugía
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsFundación Universitaria de Ciencias de la Salud-FUCS. - 2017
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/29
dc.subjectAnticonvulsivantes
dc.subjectAntipsicóticos
dc.subjectAntidepresivos
dc.subjectInteracciones medicamentosas
dc.subjectReacciones adversas
dc.subjectEfectos colaterales relacionados con medicamentos
dc.subjectAnticonvulsants
dc.subjectAntipsychotic agents
dc.subjectAntidepressive agents
dc.subjectDrug interactions
dc.subjectAdverse reactions
dc.subjectDrug-related side effects
dc.titleInteracciones medicamentosas de los anticonvulsivantes de primera línea con antipsicóticos y/o antidepresivos
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución